Related Experiment Video
Updated: May 8, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis
Benjamin D Humphreys1, Fengfeng Xu, Venkata Sabbisetti
1Renal Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA. bhumphreys@partners.org
Abstract:
Acute kidney injury predisposes patients to the development of both chronic kidney disease and end-stage renal failure, but the molecular details underlying this important clinical association remain obscure. We report that kidney injury molecule-1 (KIM-1), an epithelial phosphatidylserine receptor expressed transiently after acute injury and chronically in fibrotic renal disease, promotes kidney fibrosis. Conditional expression of KIM-1 in renal epithelial cells (Kim1(RECtg)) in the absence of an injury stimulus resulted in focal epithelial vacuolization at birth, but otherwise normal tubule histology and kidney function. By 4 weeks of age, Kim1(RECtg) mice developed spontaneous and progressive interstitial kidney inflammation with fibrosis, leading to renal failure with anemia, proteinuria, hyperphosphatemia, hypertension, cardiac hypertrophy, and death, analogous to progressive kidney disease in humans. Kim1(RECtg) kidneys had elevated expression of proinflammatory monocyte chemotactic protein-1 (MCP-1) at early time points. Heterologous expression of KIM-1 in an immortalized proximal tubule cell line triggered MCP-1 secretion and increased MCP-1-dependent macrophage chemotaxis. In mice expressing a mutant, truncated KIM-1 polypeptide, experimental kidney fibrosis was ameliorated with reduced levels of MCP-1, consistent with a profibrotic role for native KIM-1. Thus, sustained KIM-1 expression promotes kidney fibrosis and provides a link between acute and recurrent injury with progressive chronic kidney disease.
Insights
Kidney injury molecule-1 (KIM-1) promotes kidney fibrosis and chronic kidney disease progression. Sustained KIM-1 expression links acute kidney injury to progressive renal failure, offering a potential therapeutic target.
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- Acute kidney injury (AKI) increases risk for chronic kidney disease (CKD) and end-stage renal failure.
- The molecular mechanisms linking AKI to CKD are not fully understood.
- Kidney injury molecule-1 (KIM-1) is an epithelial phosphatidylserine receptor expressed after kidney injury.
Purpose of the Study:
- To investigate the role of KIM-1 in promoting kidney fibrosis and CKD.
- To elucidate the molecular pathways by which KIM-1 contributes to renal disease progression.
Main Methods:
- Conditional expression of KIM-1 in renal epithelial cells (Kim1(RECtg)) in mice.
- Analysis of kidney histology, function, and molecular markers in Kim1(RECtg) mice.
- In vitro studies using immortalized proximal tubule cells expressing KIM-1.
- Assessment of experimental kidney fibrosis in mice with mutant KIM-1.
Main Results:
- Kim1(RECtg) mice developed spontaneous, progressive interstitial kidney inflammation and fibrosis, leading to renal failure.
- Elevated monocyte chemotactic protein-1 (MCP-1) expression was observed in Kim1(RECtg) kidneys.
- KIM-1 expression triggered MCP-1 secretion and enhanced macrophage chemotaxis in vitro.
- A mutant, truncated KIM-1 ameliorated experimental kidney fibrosis and reduced MCP-1 levels.
Conclusions:
- Sustained KIM-1 expression promotes kidney fibrosis and progression to chronic kidney disease.
- KIM-1 acts via MCP-1 to drive inflammation and fibrosis, linking acute injury to progressive renal failure.
- KIM-1 represents a potential therapeutic target for preventing CKD progression after AKI.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Nephrons
Acute Kidney Injury I: Introduction
Chronic Kidney Disease I: Introduction
